You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
《半新股》海普瑞(09989.HK)逆市急漲11%重越20天線 A股漲停
阿思達克 08-06 11:27
恆指反彈受制25,200,掉頭失守10天及50天線,曾急吐461點或1.8%低見24,641喘定,現跌357點或1.4%報24,744;國指也吐1.1%曾低見10,093。

不過,半新醫藥股海普瑞(09989.HK)承昨天倒升結束三連跌後,今早逆市急漲重越10天及20天線(16.07元及16.8元),最高見17.8元,仍受制上市價18.4元,現造17.58元,急漲11%,成交急增至1,029萬股,涉資1.77億元;其A股漲停報27.9元人民幣。

海普瑞是內地領先製藥公司,在製藥領域、創新生物科技領域及CDMO領域擁有全球業務。股份於7月8日以每股18.4元來港上市,但上市後股價僅三個交易日盤中曾企穩於上市價之上,最高見18.98元,餘下均「潛水」。公司上月底公布,於穩定價格期,聯席全球協調人並無行使超額配股權,相關配股權已失效。

海普瑞本周一公布,向子公司美國海普瑞增資不超6.9895億元人民幣。完成後,美國海普瑞的投資總額將增至不超過2.13億美元,仍為公司全資子公司。另外,海普瑞上月中預計,上半年賺5.46-6.01億人民幣,按年最多增長10%。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account